Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About James Sapirstein

James Sapirstein is recorded as Board Member at ZyVersa Therapeutics, Inc. (ZVSA), CEO at Cocrystal Pharma, Inc. (COCP) and Chairman and Board Member at Onconetix, Inc. (ONCO). Cocrystal Pharma, Inc. reported in an 8-K filed June 9, 2026 that James Sapirstein was appointed Chief Executive Officer, effective June 3, 2026. Onconetix, Inc. reported in an 8-K filed April 3, 2025 that James Sapirstein resigned as member of the Board of Directors, effective March 28, 2025. Onconetix, Inc. reported in an 8-K filed April 3, 2025 that James Sapirstein resigned as Executive Chairman, effective March 28, 2025. Equibles holds 8 filed executive changes naming James Sapirstein; each is listed under recent activity with its source filing.

“On June 3, 2026, the Board of Directors (the "Board") of Cocrystal Pharma, Inc. (the "Company") appointed James Sapirstein as the Chief Executive Officer of the Company, effective immediately, pursuant to the terms of an employment offer letter (the "Offer Letter").”
Cocrystal Pharma, Inc. Form 8-K, filed June 9, 2026 · Read the filing
“Effective as of March 28, 2025, James Sapirstein resigned as Executive Chairman and a member of the Board of Directors (the "Board") of Onconetix, Inc. (the "Company").”
Onconetix, Inc. Form 8-K, filed April 3, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Cocrystal Pharma, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Onconetix, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at ZyVersa Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.